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Ultraparamagnetic cells formed through intracellular oxidation and 
chelation of paramagnetic iron 
Pradeep Ramesha, Son-Jong Hwangb, Hunter C. Davisb, Audrey Lee-Gosselinb, Vivek Bharadwajc, 
Max A. Englishb, Jenny Shengc, Vasant Iyerc, Mikhail G. Shapirob,*
Abstract: Making cells magnetic is a long-standing goal of chemical 
biology, aiming to enable the separation of cells from complex 
biological samples and their visualization in vivo using magnetic 
resonance imaging (MRI). Previous efforts towards this goal, focused 
on engineering cells to biomineralize superparamagnetic or 
ferromagnetic iron oxides, have been largely unsuccessful due to the 
stringent required chemical conditions. Here, we introduce an 
alternative approach to making cells magnetic, focused on 
biochemically maximizing cellular paramagnetism. We show that a 
novel genetic construct combining the functions of ferroxidation and 
iron chelation enables engineered bacterial cells to accumulate iron 
in “ultraparamagnetic” macromolecular complexes, allowing these 
cells to be trapped with magnetic fields and imaged with MRI in vitro 
and in vivo. We characterize the properties of these cells and 
complexes using magnetometry, nuclear magnetic resonance, 
biochemical assays, and computational modeling to elucidate the 
unique mechanisms and capabilities of this paramagnetic paradigm. 
Inspired by magnetotactic bacteria, chemical and synthetic 
biologists have attempted to impart ferromagnetism or 
superparamagnetism onto non-magnetic microbial and eukaryotic 
cell types to enable their localization and isolation from complex 
samples using magnetic fields and visualization with magnetic 
resonance imaging (MRI)[1–4]. Such capabilities would facilitate, 
for example, the study of commensal and pathogenic microbes 
inside mammalian hosts and the development of magnetically 
engineered microbial diagnostic and therapeutic agents[5,6]. 
However, because of the stringent pH, iron concentrations and 
redox potentials required for the synthesis of magnetosomal 
magnetite and other forms of superparamagnetic or 
ferromagnetic iron oxides, attempts to engineer the formation of 
these minerals in natively non-magnetic species such as E. coli 
have had limited success[7–11].  
Here, we introduce an alternative paradigm for producing 
magnetic cells that is focused on maximizing cellular 
paramagnetism rather than forming superparamagnetic or 
ferromagnetic deposits. This approach arises from the recognition 
that many applications of magnetic cells, including MRI and 
cellular separation, involve multi-Tesla magnetic fields, in which 
sufficiently paramagnetic cells would be expected to act as 
microscale magnets, capable of producing MRI contrast and 
experiencing magnetic gradient forces for localization and 
separation (Fig. 1A)[12,13]. With such “ultraparamagnetism” as the 
stated goal, ferritin – the main iron storage protein in most cells 
and the focal point of previous efforts in magnetic cell engineering 
– represents a relatively poor iron host because most of the 
electron spins in its ferrihydrite core are cancelled by 
antiferromagnetic partners, such that its net paramagnetic 
moment equates to only ~5% of the available spin at 37 ºC [14,15].  
We hypothesized that better use of intracellular iron could 
be made by cells expressing a protein construct specifically 
designed to nucleate and chelate iron in a paramagnetic 
configuration. In this work, we engineer such a construct, 
characterize it physically and biochemically, and show that E. coli 
expressing it have 8-fold stronger paramagnetism than ferritin-
overexpressing controls. This allows these cells to be localized 
via magnetic field gradients, visualized with MRI, and isolated 
from complex biological samples.   
 
 
 
Figure 1 – Ultraparamagnetic gene circuit.| A. Paramagnetic cells produce 
magnetic fields and experience force when placed inside a strong magnetic field, 
such as in an MRI scanner. B. UPMAG gene circuit, comprising a ferroxidase 
(FLP) fused to a magnetite nucleating peptide (M6A), and a ferrous iron 
transporter (EfeU). The circuit is driven using an IPTG-inducible T5 phage 
promoter. The ferrous iron transporter increases the intracellular iron content 
available to FLPM6A. FLPM6A then forms macromolecular assemblies with 
oxidized iron. 
 
To produce and store intracellular iron in a paramagnetic 
state, we created a fusion protein combining the decameric 
ferroxidase FLP from Rhodospirillum Rubrum with the iron-
binding peptide M6A derived from the last 20 C-terminal residues 
of the Mms6 protein from Magnetospirillum magneticum (Fig. 
1B)[16,17]. Iron can be imported into E.coli as Fe2+, but must be 
oxidized to avoid the production of toxic radicals via the Haber-
Weiss reaction[18]. We specifically chose FLP for this purpose 
because it can effectively oxidize ferrous iron, but does not on its 
own mineralize the iron into potentially poorly magnetic iron 
oxides[16]. This stands in contrast to ferritin, which both oxidizes 
iron and stores it as an antiferromagnetic mineral. The second 
component, M6A, was previously shown to promote and stabilize 
the nucleation of magnetic iron species in vitro[17,19]. We 
hypothesized that, after FLP oxidizes iron to Fe3+, M6A would bind 
any available ferrous iron as well as oxidized ferric iron and 
promote the nucleation of small iron oxide minerals[20], stabilized 
by multiple M6A binding interactions (Fig. 1B). We predicted that 
this iron would remain in a loosely ordered, strongly paramagnetic 
state (Fig. 1B). As control constructs, we generated E. coli 
overexpressing bacterioferritin (BFR) or fluorescent proteins (FP: 
mRuby2 or eGFP). BFR was chosen as our standard for 
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comparison based on its previous use as a genetically encoded 
contrast agent for MRI [21]. All vectors also included the iron 
transporter EfeU from E. coli Nissle 1917 to facilitate the uptake 
of ferrous iron from the growth medium. These constructs were 
expressed in a model strain of E. coli (BL21 DE3) with no 
additional alterations to endogenous iron-handling genes. The 
complete genetic circuit consisting of  FLPM6A and EfeU is 
hereafter referred to as UPMAG, for UltraParaMagnetic Genes.  
 
 
 
Figure 2 – UPMAG cells are strongly paramagnetic. | A. Bulk volume 
susceptibility measurements of E. coli at room temperature. B. Quantification of 
intracellular iron in E. coli expressing UPMAG, FP or BFR. C. SQUID MPMS 
measurement of the magnetic moment at constant temperature of 30K while the 
magnetic field was swept. D. SQUID MPMS zero-field cooled measurement of 
the magnetic susceptibility under a bias field of 500 Oe while the temperature 
was swept.  
 
As a first step in characterizing the magnetism of UPMAG 
expressing E. coli relative to controls, we measured their 
magnetic susceptibility at room temperature. As expected, control 
cells expressing FP were weakly diamagnetic, with a bulk 
susceptibility (Dc) of -0.05 ± 0.05 ppm. In contrast, cells 
expressing UPMAG exhibited strong paramagnetism, with a Dc of 
4.68 ± 0.08 ppm (Fig. 2A). This magnetic susceptibility was 
approximately 8-fold stronger than in weakly paramagnetic cells 
overexpressing BFR (Dc = 0.61 ± 0.06 ppm). Using the ferrozine 
assay, we found that cells expressing UPMAG contained 3.33 ± 
0.20 fg iron per cell (Fig. 2B), such that the measured Dc 
represents 50.7% of the theoretical maximum for high-spin iron 
(Supplementary Table 1). In contrast, BFR cells contained 1.89 
± 0.09 fg iron, such that their 8-fold lower susceptibility means 
they derive less than ¼ the per iron-atom magnetism of UPMAG. 
In a superconducting quantum interference device (SQUID) 
magnetometer, the magnetic moment of UPMAG cells had a 
positive linear dependence on the applied magnetic field and a 
Curie-Weiss dependence on temperature, (Fig. 2, C-D) indicative 
of paramagnetism[14]. In comparison, BFR cells showed weaker 
paramagnetism and no evidence of ferrimagnetism at 30K, 
consistent with the literature[14], while FP cells were diamagnetic. 
Together, these results indicate that the expression of UPMAG 
causes intracellular iron to accumulate in a much more strongly 
paramagnetic state than controls. Mössbauer spectroscopy on 
UPMAG cells at 80K indicated a composition of mainly high-spin 
ferric iron (96.5%), in a state consistent with intracellular 
ferrihydrite[22] (Supplementary Fig. S1A). 
 To assess the impact of UPMAG expression on cell viability, 
we monitored cell culture density after induction to express either 
UPMAG or FP controls, in the presence of ferrous ammonium 
sulfate. We found that both the growth rate and the final density 
were similar in both cases (Supplementary Fig. S2 A-D). 
To determine whether an enhanced paramagnetic 
phenotype can enable the manipulation of UPMAG cells using 
magnetic fields, we first assessed their ability to be retained in 
magnetically actuated cell sorting (MACS) separation 
columns[23][24]. We found that E. coli expressing UPMAG were 
retained in MACS columns with 40 ± 2.8 % efficiency – much 
greater than either FP or BFR cells. (Fig. 3A). To visualize how 
UPMAG E. coli could be spatially manipulated with strong 
magnetic fields, we incubated a suspension of UPMAG cells 
overnight in a petri dish sitting on top of N52 NdFeB magnets (Fig. 
3B). The estimated 100 T/m magnetic field gradients 1 mm away 
from the magnet surface (Fig. 3C) caused the bacteria to become 
concentrated in areas of maximal field strength (Fig. 3D). 
 
 
Figure 3 – UPMAG cells can be captured and localized with magnetic fields. 
A. Magnetic column retention of UPMAG expressing E. coli relative to controls 
in a MACS LD column. B. N52 NdFeB magnets were placed above and below 
a petri dish containing E.coli expressing either UPMAG or FP in M9 base media 
and left overnight. C. Simulated magnetic field of the bar magnets used in the 
experiment, showing sharp field gradients at the edges of the magnet (~ 100 
T/m). D. Photos taken after overnight incubation of E.coli expressing UPMAG 
or controls in Petri dishes placed above the magnets. 
 
To assess whether the cellular paramagnetism conferred by 
UPMAG could be used for noninvasive cellular imaging in addition 
to magnetic actuation, we imaged cells expressing this construct 
with MRI.  When imaged in agarose phantoms at 7 Tesla, UPMAG 
cells produced T2 contrast relative to both background and 
controls at densities as low as 1 × 10$%, colony forming units (cfu) 
per ml, corresponding to a cellular volume fraction of 3.6 % (Fig. 
4A)[25]. In contrast, cells expressing FP required at least 3-fold 
higher concentrations to be comparably visualized relative to 
background. Overexpression of BFR led to only a modest 
increase in T2 contrast relative to FP, as expected based on the 
fact that E.coli cultured in iron-rich media also upregulate the 
expression of endogenous ferritins such as ftnA, ftnB, and BFR[26–
28].  
Quantitative NMR measurements at 11.7 Tesla showed that 
solutions of E. coli expressing UPMAG had 70% faster relaxation 
rates compared to controls at cell optical density OD10 (Fig. 4B), 
with a cellular T2 relaxivity of approximately 3.4	 *+,-./0122 , or 
equivalently a per-iron relaxivity of 20.7	mM7$sec7$ , as 
determined by linear fit. Monte Carlo simulations of water diffusion 
and spin precession in media containing ultraparamagnetic 
bacteria further revealed that most of the observed T2 relaxation 
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enhancement can be explained by diffusional water exchange 
between the bulk and the Dc-shifted cell interior (Fig. 4, C-D, 
Supplementary Fig. S3A). T1 relaxivity was similar between 
UPMAG cells and controls (Supplementary Fig. S3B).  
After establishing the basic capabilities of UPMAG 
expressing cells in vitro, we proceeded to test them in proof-of-
concept in vivo applications. First, to test whether UPMAG 
enables cellular imaging in the context of a living animal, we 
injected E. coli expressing either UPMAG or control constructs in 
a hydrogel subcutaneously into the hind flanks of mice (Fig. 5A). 
T2 weighted images at 7 Tesla showed clear contrast in regions 
containing UPMAG cells compared to controls (Fig. 5B), and T2 
in regions of interest containing these cells was significantly 
shorter than in regions containing control cells (Fig. 5C). 
 
Figure 4 – UPMAG cells produce enhanced MRI contrast. | A. A T2 weighted 
image of E.coli in an agarose phantom, acquired at 7 Tesla using a spin echo 
sequence with TR = 2500 ms and TE = 11 ms. B. R2 vs. OD600 for E.coli 
expressing either UPMAG or controls in a Bruker 500 MHz NMR spectrometer 
with a spin echo sequence and TE = 0.5 ms. C. Schematic of two potential 
mechanisms of T2 contrast, one in which water relaxes due to extracellular 
outer-sphere dipole relaxation, and a second in which water relaxes via 
diffusional exchange into the intracellular compartment. D. Monte Carlo 
simulation results for cells at OD600 = 10, in comparison with experimental data. 
 
In addition to imaging, a major challenge in studying the in 
vivo function of host-associated bacteria is their isolation from 
host materials and other microbes. We hypothesized that 
magnetic fields could be used to rapidly isolate ultraparamagnetic 
microbes from mixed fecal samples after passage through the 
gastrointestinal (GI) tract (Fig. 5D). Such a capability is relevant 
for the study of GI-resident microbial populations and the 
development of sentinel cells engineered to sense and report on 
the presence of GI pathology[29], providing a fast way to separate 
engineered cells from native gut microbes and other fecal 
contents, compared to conventional alternatives such as growth 
on selective media.  
To provide a proof of concept for this approach, we mixed 
UPMAG cells with a 10-fold excess of control FP microbes and 
gavaged the mixture into BALB/c mice. A subset of the gavage 
mixture was also subjected to MACS in vitro to corroborate the in 
vivo experiments (Supplementary Fig. S4 A-B). After allowing 
time for bacterial passage through the GI tract, we collected feces, 
homogenized them, and performed MACS - the effectiveness of 
which was assessed by plating on selective media (Fig. 5E). We 
found that UPMAG cells were enriched 315 ± 48  fold in the 
MACS eluate relative to their initial abundance (Fig. 5F). The 
genetic identity of each cell type was confirmed using DNA 
sequencing in a subset of colonies. These results suggest that the 
magnetic functionality of UPMAG cells can be employed in 
complex biological samples. 
 
 
Figure 5 – UPMAG cells can be detected in vivo and magnetically isolated 
from ex vivo specimens. | A. Schematic of subcutaneous contralateral 
injections of E.coli expressing either control or UPMAG into the hind flanks of 
NU/J mice. B. Representative MRI image of mouse at 7 Tesla using a T2 RARE 
sequence (TR = 5000 ms, TE = 11 ms, RARE factor = 2). C. In vivo relaxation 
rates obtained from pixelwise fitting in Matlab and averaging over the relevant 
ROIs. D. Schematic of the in vivo gavage experiment. E. Representative image 
of plates containing the flow-through and eluted fractions. Non-fluorescent 
colonies contain the UPMAG vector, as confirmed by DNA sequencing. F. Ratio 
of UPMAG to FP cells in the respective MACS fractions. 
 
Finally, to gain insight into both FLPM6A and the nature of 
the paramagnetic material formed inside UPMAG cells, we 
performed biochemical assays on purified FLPM6A, which was 
augmented with an N-terminal hexa-histidine tag for affinity 
purification. When expressed in E. coli in the absence of iron 
supplementation, FLPM6A could be found in the soluble fraction 
of the cell lysate, allowing us to purify it using Ni-NTA affinity 
purification (Fig. 6A, Supplementary Fig S5A). Purified FLPM6A 
migrates similarly to its expected molecular weight of ~ 160 kDa 
in size-exclusion chromatography, and appears alpha-helical in 
circular dichroism spectroscopy (Supplementary Fig S5 B-C). 
This molecular weight corresponds to ten units of FLPM6A, as 
expected based on the FLP being a decamer.[16] A western blot 
against denatured FLPM6A indicates the presence of the dimer 
at ~32 kDa (Supplementary Fig S5D), which is also consistent 
with the published behavior of FLP in SDS electrophoresis.[16]  
Strikingly, when expressed in the presence of 1 mM ferrous 
iron, FLPM6A moved to the insoluble inclusion body fraction of 
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4 
the lysate (Fig. 6A), together with approximately 98% of the total 
cellular iron (Fig. 6B), suggesting that this protein and iron form a 
stable intracellular complex. To investigate the nature of this 
complex, we incubated purified FLPM6A with ferrous iron at 
different molar ratios. At iron:protein ratios above 160, the protein 
formed a visible “ferrogel” (Fig. 6C). Dynamic light scattering 
(DLS) confirmed the formation of large macromolecular 
assemblies under these conditions (Fig. 6D). Control samples 
containing a purified hexa-histidine-tagged fluorescent protein, 
and iron by itself, did not exhibit the same assembly behavior 
(Supplementary Fig. S6, A-B). Native gel electrophoresis 
revealed a reduction in protein mobility with increasing iron 
concentrations, with complexes formed at an iron:protein ratio of 
320 failing to migrate into the gel (Fig. 6E). Prussian Blue iron 
staining of the same gel indicated that iron was co-localized with 
the large protein complexes (Fig. 6F). Brightfield images of such 
complexes showed an amorphous macromolecular aggregate 
(Supplementary Fig. S6C). Transmission electron micrographs 
of these complexes likewise showed an amorphous, electron 
dense structure (Supplementary Fig. S7 A-B).  Notably, the 
approximate ratio of intracellular iron and FLPM6A in our cellular 
experiments was 304, explaining why UPMAG cells contain iron-
rich macromolecular complexes. 
 
 
Figure 6 – FLPM6A forms a ferrogel. | A. Quantity of FLPM6A in the soluble 
and insoluble fractions of cell lysates after culture in the absence or presence 
of iron supplementation (1 mM Fe), quantified per ml of bacterial culture. B. Iron 
quantification of cell lysate compartments when cells expressing UPMAG are 
grown in iron-rich medium (1 mM Fe), quantified per ml of lysis buffer. C. Photo 
of tubes containing 100 µg/ml (6.5 µM) of purified FLPM6A with iron in molar 
ratios ranging from 0:1 to 320:1 [Fe]:[FLPM6A]. D. DLS autocorrelation plots 
corresponding to the sample conditions in (C). E. Native-PAGE gel of FLPM6A 
samples corresponding to the conditions in (C). F. Prussian Blue staining of the 
same Native-PAGE gel. 
 
Taken together, our results demonstrate that the expression 
of a three-component genetic circuit renders a model bacterial cell 
ultraparamagnetic at room temperature. The eight-fold increase 
in the total paramagnetic moment of the cell is sufficient to not 
only enable more sensitive detection using MRI relative to BFR[21], 
but also to facilitate magnetic capture and enrichment from 
complex biological samples. These capabilities could enable new 
applications in chemical and synthetic biology, such as the 
tracking and rapid isolation and subsequent phenotyping of 
genetically engineered gut probiotics. The fact that the 
ultraparamagnetism is genetically encoded provides an 
advantage over previously reported approaches requiring cellular 
labeling with synthetic materials, which would become diluted 
during cell proliferation. While many previous efforts have focused 
on genetically mimicking the superparamagnetism or 
ferromagnetism of synthetic materials and magnetotactic bacteria, 
our work shows that paramagnetism is a viable alternative 
paradigm to achieving magnetic behavior under the field 
conditions employed in many envisioned applications (e.g. MACS 
and MRI). The experiments performed in this study provide the 
rudimentary proofs-of-concept for the capabilities provided by 
maximizing the paramagnetic moment of an engineered cell. 
Future studies are needed to evaluate the performance of the 
UPMAG circuit or similar constructs in more complex settings, 
such as cells residing in an animal host and in additional microbial 
species[30]. Furthermore, additional insights on the composition of 
the iron complexes from electron microscopy[31,32] could further 
the development and optimization of the UPMAG approach. Since 
the construct described in this work provides only 50.7% of the 
paramagnetism theoretically possible for the measured quantity 
of intracellular iron, there is considerable room to make UPMAG 
more “ultra”. 
Experimental Section 
Experimental methods and supplementary data can be found in 
the Supporting Information. 
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